<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; AIMS: Ras genes are the most frequently detected oncogenes in human <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Data regarding the frequency of c-K-ras mutations in esophageal, gastric, and <z:e sem="disease" ids="C0345832" disease_type="Neoplastic Process" abbrv="">small bowel tumors</z:e> are limited and controversial </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: DNA was extracted from 262 formalin-fixed, paraffin-embedded sections of gastrointestinal samples and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, including <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, esophageal <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> and <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, and small and large bowel <z:mpath ids='MPATH_270'>adenomas</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The presence of c-K-ras codon 12 mutations was determined using a nonradioactive polymerase chain reaction-based restriction fragment length polymorphism assay </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: c-K-ras mutations were detected in 1 of 39 (2%) patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, 1 of 21 (5%) <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, 0 of 27 <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> of the esophagus, and 1 of 32 (3%) <z:mp ids='MP_0008010'>gastric adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>It was also present in 8 of 20 (40%) and 10 of 28 (36%) small bowel <z:mpath ids='MPATH_270'>adenomas</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Similar numbers were observed in 10 of 25 (40%) large bowel <z:mpath ids='MPATH_270'>adenomas</z:mpath> and 11 of 30 <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> (37%) </plain></SENT>
<SENT sid="7" pm="."><plain>Mutations were not associated with age, gender, histology, grade, stage, location, or mortality </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The frequency of codon 12 c-K-ras mutations in small and <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">large bowel tumors</z:e> is approximately 10-fold higher than that of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in the upper gastrointestinal tract </plain></SENT>
</text></document>